Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A.
European journal of haematology
View this publicationMember
Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53127 Bonn
European journal of haematology
View this publicationThe Lancet. Haematology
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publication